HOUSTON, TX -- (Marketwired) -- 05/01/15 -- Nobilis Health Corp. (NYSE MKT: HLTH) (TSX: NHC) (Nobilis) today announced the voting results from its annual shareholder meeting held on April 30, 2015 (the "Meeting"). The Company's shareholders elected Harry Fleming, Richard Ganley, Jennifer Houser (Pfahler), and Steve Ozonian as directors of the Company by the following vote totals.
Directors Votes For Votes Withheld
Harry Fleming 25,867,868 234,000
Richard Ganley 25,364,568 737,300
Jennifer Pfahler 24,939,943 1,161,925
Steven Ozonian 26,061,443 40,425
The shareholders approved the proposal to ratify the appointment of Calvetti Ferguson, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2015.
Votes For Votes Against Votes Withheld
28,101,543 0 226,716
The shareholders approved the continuation of the Company's Stock Option Plan and authorization and approval of all unallocated stock options issuable pursuant to the Company's Stock Option Plan by the following vote totals.
Votes For Votes Against Votes Withheld
21,386,096 4,715,772 0
Nobilis also announces the resignation of Harry Fleming as the company's President. Mr. Fleming will continue with the company as Executive Chairman of the Board and will continue to lead the company's mergers and acquisitions activities. "With our recently announced funding we now have the capacity to entertain larger and more profitable opportunities while continuing to seek out distressed facilities that can be acquired at very reasonable prices and can immediately benefit from Nobilis' marketing platform," said Mr. Fleming. "There are tremendous opportunities in our near future and we expect to continue our aggressive acquisition strategy to complement our organic growth," added Mr. Fleming.
"Harry Fleming has led the Company through a period of tremendous growth, not only in terms of our stock price, but also in terms of our revenues, profits, operational footprint, marketing reach and employee base, among others," said Christopher Lloyd, CEO. "Now that the management teams are fully integrated, we have the depth to handle the additional revenue streams and operations that will accrete through acquisition," continued Mr. Lloyd.
About Nobilis Health Corp.
Nobilis owns and manages ambulatory and acute care facilities to deliver healthcare services. Our focus is improving access to care and patient outcomes by providing minimally invasive procedures that can be performed in low-cost, outpatient settings. We utilize innovative direct-to-patient marketing and proprietary technologies to drive patient engagement and education, resulting in added surgical volume and outsized returns to investors. Nobilis owns and manages seven surgical facilities in Dallas, Houston, and Scottsdale and has contractual partnerships with six other facilities in Arizona, Oregon, Michigan, Minnesota, Tennessee and New Jersey.
Forward-looking statements
This news release may contain forward-looking statements (within the meaning of applicable securities laws) and financial outlooks relating to the business of Nobilis Health Corp. (the "Company") and the environment in which it operates. Forward-looking statements are identified by words such as "believe", "anticipate", "expect", "intend", "plan", "will", "may" and other similar expressions and may discuss future expectations, contain projections of future results of operations or of financial condition, or state other forward-looking information. These statements are based on the Company's expectations, estimates, forecasts and projections and while the Company considers these to be reasonable based on information currently available, they may prove to be incorrect. They are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. These risks and uncertainties are discussed in the Company's regulatory filings available on the Company's web site at www.NobilisHealth.com, www.Sedar.com and in the risk factors described in the Company's Form 10-K for the fiscal year ended December 31, 2014, filed on April 2, 2015. There can be no assurance that forward-looking statements will prove to be accurate as actual outcomes and results may differ materially from those expressed in these forward-looking statements. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, a forward-looking statement speaks only as of the date on which such statement is made. Other than as required by law, the Company undertakes no obligation to publicly update any such statement or to reflect new information or the occurrence of future events or circumstances.
